The following areas are of interest to Investigator Studies Program Committee:
- Studies investigating modifications of corifollitropin alfa (CFA) stimulation protocols to the freeze-all setting aimed at optimizing ART cycle outcomes, time to pregnancy, flexibility and cost-efficiency.
- Studies investigating optimizing CFA use in patients with a predicted poor oocyte yield response.
- Studies that use innovative technology and algorithms to enhance embryo selection with CFA vs. conventional gonadotropins.
- Studies that evaluate further optimization of the post-CFA follicular stimulating hormone (rFSH) regimen and determine the parameters to support optimization (e.g. # follicles, age, endocrine environment)
- Studies evaluating Progestin Primed Ovarian Stimulation (PPOS) in CFA versus recombinant (r)FSH cycles for ovarian response and donor compliance
- Evaluate the effect of modifications of ovarian stimulation on late follicular progesterone rise (eg. CFA, recombinant Luteinizing Hormone, human Menopausal Gonadotropin
Deadline: Rolling deadline
Dollar Amount: Varies
Eligibility: Investigators at all career levels are eligible to apply
Full RFP: http://engagezone.msd.com/fertility.php